Abstract:A nano-micellar system (O-CMCTS-VES) constituted by carboxymethyl chitosan and vitamin E succinate was fabricated.The micelles hold high cytocompatibility, hemocompatibility, tissue compatibility, and drug load contents.Drug release experiments implied good pH sensitivity and sustained-release effect of O-CMCTS-VES.O-CMCTS-VES loading DOX showed efficient anti-tumor effect in vitro and in vivo.Nanocarriers have emerged as a promising cancer drug delivery strategy. Multi-drug resistance caused by overexpression of multiple-drug excretion transporters in tumor cells is the major obstacle to successful chemotherapy. Vitamin E derivatives have many essential functions for drug delivery applications, such as biological components that are hydrophobic, stable, water-soluble enhancing compounds, and anticancer activity. In addition, vitamin E derivatives are also effective mitocan which can overcome multi-drug resistance by binding to P glycoproteins. Here, we developed a carboxymethyl chitosan/vitamin E succinate nano-micellar system (O-CMCTS-VES). The synthesized polymers were characterized by Fourier Transform IR, and 1H NMR spectra. The mean sizes of O-CMCTS-VES and DOX-loaded nanoparticles were around 177 nm and 208 nm. The drug loading contents were 6.1%, 13.0% and 10.6% with the weight ratio of DOX to O-CMCTS-VES corresponding 1:10, 2:10 and 3:10, and the corresponding EEs were 64.3%, 74.5% and 39.7%. Cytotoxicity test, hemolysis test and histocompatibility test showed that it had good biocompatibility in vitro and in vivo. Drug release experiments implied good pH sensitivity and sustained-release effect. The DOX/O-CMCTS-VES nanoparticles can be efficiently taken up by HepG2 cancer cells and the tumor inhibition rate is up to 62.57%. In the in vivo study by using H22 cells implanted Balb/C mice, DOX/O-CMCTS-VES reduced the tumor volume and weight efficiently with a TIR of 35.58%. The newly developed polymeric micelles could successfully be utilized as a nanocarrier system for hydrophobic chemotherapeutic agents for the treatment of solid tumors.Schematic diagram of the O-CMCTS-VESnanoparticles with EPReffect for anticancer therapy.<ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2452199X2100089X-ga1_lrg.jpg">Download : Download high-res image (309KB)</a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2452199X2100089X-ga1.jpg">Download : Download full-size image</a></li></ol>

In vitro/vivo antitumor study of modified-chitosan/carboxymethyl chitosan “boosted” charge-reversal nanoformulation

Chitosan/o-carboxymethyl Chitosan Nanoparticles for Efficient and Safe Oral Anticancer Drug Delivery: in Vitro and in Vivo Evaluation.

Synthesis and in Vitro Characterization of Carboxymethyl Chitosan-CBA-Doxorubicin Conjugate Nanoparticles As Ph-Sensitive Drug Delivery Systems

Sodium Dodecyl Sulfate-Modified Doxorubicin-Loaded Chitosan-Lipid Nanocarrier with Multi Polysaccharide-Lecithin Nanoarchitecture for Augmented Bioavailability and Stability of Oral Administration in Vitro and in Vivo.

A smart O2-generating nanocarrier optimizes drug transportation comprehensively for chemotherapy improving

The design and synthesis of dextran-doxorubicin prodrug-based pH-sensitive drug delivery system for improving chemotherapy efficacy

Enhanced Targeted Delivery of Doxorubicin Based on Acid Induced Charge Reversal and Combinational Stimuli‐Responsive Nanocarrier

In vitro/vivo evaluation of novel mitochondrial targeting charge-reversal polysaccharide-based antitumor nanoparticle

Enhanced Cellular Internalization and On-Demand Intracellular Release of Doxorubicin by Stepwise Ph-/Reduction-responsive Nanoparticles.

Fluorinated Carboxymethyl Chitosan-Based Nano-Prodrugs for Precisely Synergistic Chemotherapy

Arginine-Modified Nanostructured Lipid Carriers with Charge-Reversal and Ph-Sensitive Membranolytic Properties for Anticancer Drug Delivery

A chitosan/mesoporous silica nanoparticle-based anticancer drug delivery system with a “tumor-triggered targeting” property

Ph-Sensitive Deoxycholic Acid Dimer for Improving Doxorubicin Delivery and Antitumor Activity in Vivso.

Enhanced cytotoxicity of core modified chitosan based polymeric micelles for doxorubicin delivery.

Charge-Convertible and Reduction-Sensitive Cholesterol-Containing Amphiphilic Copolymers for Improved Doxorubicin Delivery

Negative Surface Shielded Polymeric Micelles with Colloidal Stability for Intracellular Endosomal/Lysosomal Escape.

A Ph-Responsive Glycolipid-Like Nanocarrier for Optimising the Time-Dependent Distribution of Free Chemical Drugs in Focal Cells.

Multilayer Sodium Alginate Beads with Porous Core Containing Chitosan Based Nanoparticles for Oral Delivery of Anticancer Drug

Improved Cytotoxicity of Doxorubicin by Enhancing Its Nuclear Delivery Mediated Via Nanosized Micelles.

Efficient drug delivery and anticancer effect of micelles based on vitamin E succinate and chitosan derivatives

Dual-pH Sensitive Charge-Reversal Drug Delivery System for Highly Precise and Penetrative Chemotherapy